RxDoctor Payments Data

Anne Barlow Barry, DO

Family Medicine · Windham, NHNPI 1518195841

Payments from drug & device makers

$776in general payments, 2019–2025

Across 35 payments — averaging $22.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$167
  • AbbVie$158
  • Pfizer$101
  • AstraZeneca$96
  • GSK$62
  • Novartis$41
  • plus $150 from 7 others

What the payments were for

  • Food & beverage$776100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$776 in reported general payments places this provider in the 80th percentile of 397 family medicine providers in New Hampshire.

See all family medicine providers in New Hampshire

Medicare billing

Part B allowed, 2024
$228,448
Medicare patients
556
Services billed
3,061

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban42$50,810
OzempicSemaglutide33$45,185
XareltoRivaroxaban26$25,696
JardianceEmpagliflozin15$18,119
MounjaroTirzepatide11$11,341
Atorvastatin Calcium300$2,859
Metoprolol Succinate135$1,961
Venlafaxine Hcl ErVenlafaxine Hcl30$1,801
Bupropion XlBupropion Hcl50$1,768
Rosuvastatin Calcium72$1,740
Levothyroxine Sodium208$1,528
Albuterol Sulfate HfaAlbuterol Sulfate44$1,390
Omeprazole72$1,191
Amlodipine Besylate186$1,189
Lisinopril219$1,103

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$101$50,81042 claims
Novo NordiskOzempic$39$45,18533 claims
Lilly USA, LLCMounjaro$31$11,34111 claims
AbbVieSynthroid$158$79525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 397 family medicine providers in New Hampshire.

Other family medicine in Windham

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →